Cargando…
Baicalein Enhances the Oral Bioavailability and Hepatoprotective Effects of Silybin Through the Inhibition of Efflux Transporters BCRP and MRP2
Although hepatoprotective properties of silybin are well documented, the clinical therapeutic efficacy is limited by its low bioavailability due to absorption rates, extensive phase II metabolism, and biliary excretion. As our previous study indicated that metabolic enzymes may have limited effects...
Autores principales: | Xu, Peng, Zhou, Hua, Li, Ya-Zhuo, Yuan, Zhong-Wen, Liu, Chang-Xiao, Liu, Liang, Xie, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6212553/ https://www.ncbi.nlm.nih.gov/pubmed/30416442 http://dx.doi.org/10.3389/fphar.2018.01115 |
Ejemplares similares
-
Folium Sennae Increased the Bioavailability of Methotrexate through Modulation on MRP 2 and BCRP
por: Yu, Chung-Ping, et al.
Publicado: (2021) -
The Effect of Albumin on MRP2 and BCRP in the Vesicular Transport Assay
por: Deng, Feng, et al.
Publicado: (2016) -
Polarized macrophage subsets differentially express the drug efflux transporters MRP1 and BCRP, resulting in altered HIV production
por: He, Hui, et al.
Publicado: (2018) -
Uric acid transporters BCRP and MRP4 involved in chickens uric acid excretion
por: Ding, Xuedong, et al.
Publicado: (2019) -
Characterization of SN38-resistant T47D breast cancer cell sublines overexpressing BCRP, MRP1, MRP2, MRP3, and MRP4
por: Lee, Hee-Jeong, et al.
Publicado: (2022)